Science & Enterprise subscription

Follow us on Twitter

  • Results of a clinical trial show a multi-user computer game using virtual reality helps people recovering from a st… https://t.co/JjyGsh7nAj
    about 5 hours ago
  • New post on Science and Enterprise: Virtual Reality Helps Continue Stroke Rehab at Home https://t.co/yzE1i27U2I #Science #Business
    about 5 hours ago
  • Amazing guts by Hendrickson to do this interview. More than I got. Author on interview with Biden over shared exper… https://t.co/ryRKrotY9K
    about 9 hours ago
  • Researchers in the U.S. and Germany discovered a new source of antibiotics to fight drug-resistant bacteria from co… https://t.co/tPwIf9nhLB
    about 9 hours ago
  • New post on Science and Enterprise: New Antibiotic Discovered to Fight Drug-Resistant Bacteria https://t.co/wcJ3czM25x #Science #Business
    about 9 hours ago

Please share Science & Enterprise

FDA Approves Single Dual-Drug Pill for HIV

HIV released from cell

The Food and Drug Administration approved a daily pill with 2 drugs to lower viral loads in people with HIV, but who have not yet taken other HIV drugs. . . . → Read More: FDA Approves Single Dual-Drug Pill for HIV

Trial Testing Vaginal Ring, PrEP in Teens, Young Women

Vaginal ring and PrEP

A clinical trial is underway testing use and preferences for drugs or a medical device to prevent HIV infection among young women and teenage girls in Africa. . . . → Read More: Trial Testing Vaginal Ring, PrEP in Teens, Young Women

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

Infographic – HIV Infections Growing in Eastern Europe

Chart: HIV cases in Europe

While much attention is focused on the continuing AIDS and HIV crisis in Africa, countries in Eastern Europe are also facing growing numbers of HIV infections. . . . → Read More: Infographic – HIV Infections Growing in Eastern Europe

Antibody Combination Shown to Suppress HIV

T-cell infected by HIV

Results from a small-scale clinical trial show a combination of antibodies can suppress the HIV virus for many weeks after stopping antiretroviral therapy. . . . → Read More: Antibody Combination Shown to Suppress HIV

Technique Assessed for Comparing Effectiveness Between Drugs

Analytics

An academic-industry research team validated a statistical technique to evaluate the effectiveness of different drugs treating the same disease, without conducting separate head-to-head clinical trials. . . . → Read More: Technique Assessed for Comparing Effectiveness Between Drugs

HIV Drugs Formulated Into Once-Weekly Capsules

Medical and engineering researchers developed and tested in pigs a technique for packing several drugs into a capsule taken once a week to prevent and treat HIV infections. . . . → Read More: HIV Drugs Formulated Into Once-Weekly Capsules

Start-Up Lands $10M for Gene-Editing HIV Treatments

A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments

Gene Editing Could Lead to an HIV Cure

Researchers at Temple University and the University of Pittsburgh published a study, which involved gene editing to remove HIV DNA from rat and mouse models. . . . → Read More: Gene Editing Could Lead to an HIV Cure

Messenger RNA Engineered to Produce Antibodies

Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies. . . . → Read More: Messenger RNA Engineered to Produce Antibodies